Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
about
Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in ChildrenCompliance with the current recommendations for prescribing antibiotics for paediatric community-acquired pneumonia is improving: data from a prospective study in a French networkSerotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future VaccinesComment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children"A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine eraDifferences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010-2013.Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study.Surveillance of pneumococcal diseases in Central and Eastern EuropeThe multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.Necrotizing pneumonia: an emerging problem in children?Pneumococcal conjugate vaccine use in adults.The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.Recent Developments in Pediatric Community-Acquired Pneumonia.Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies.Pneumococcal pneumonia vaccine breakthroughs and failures after 13-valent pneumococcal conjugated vaccine.Evaluation of the Impact of Pneumococcal Conjugate Vaccine on Pediatric Community-Acquired Pneumonia Using an Emergency Database System.When should clinicians suspect group A streptococcus empyema in children? A multicentre case-control study in French tertiary care centres.Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.Impact of Implementing National Guidelines on Antibiotic Prescriptions for Acute Respiratory Tract Infections in Pediatric Emergency Departments: An Interrupted Time Series Analysis.Specialty Grand Challenge In Pediatric Infectious Diseases.Survey of hospital procedures for parapneumonic effusion in children highlights need for standardised management.Microbial aetiology of paediatric pneumonia complicated with parapneumonic effusion in the era of pneumococcal vaccination.Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017
P2860
Q26782280-D3F21EE6-02EA-4FC7-B781-48770857A66CQ31121439-4F2A993A-CB22-4C9D-8FED-383DBE08B1B6Q33653107-85380B72-1076-4043-9797-8BFB0561755DQ34473127-4849555A-9CC9-43D2-BF61-CD38FA78DBE9Q35716387-CC046E67-3B85-4301-8EE5-7BEEFF0F400BQ35752767-5EA0D8D8-2F70-4EDD-B015-ABF3BDA16A64Q35752770-DA97AE57-EEB2-4628-921B-5827F492C22FQ35887787-BEF447B6-D43E-4562-8A01-7B2EAD272F71Q36078775-07041DF4-5900-45E4-90B7-F6C7FA70F544Q36212036-A5039462-88F3-4412-A9FF-788B873A497EQ37010229-7B7A42ED-0A3B-49A5-BBD0-88087ACFB098Q37184742-701AE0CE-EA9C-463B-8463-12BD4A2F6393Q37197020-AD2D4C44-887E-459A-888A-297B284E52BEQ37309202-332A0309-40A9-4C93-A033-BD401AC54D7BQ38645380-B7CE9F2A-D61B-4A81-B396-29EDCE58F559Q38664425-BC44649C-4EFA-45D6-9345-DF427F2D2099Q38682463-51F12BE5-DED7-41F6-AACC-A290C7D8D3ACQ38767450-1BFE795D-1015-4C58-BE21-72A962615CE9Q38922276-E8442E68-B730-481A-8FDA-A86365C8D7D3Q38956348-10812CF0-810F-411B-BF7B-708C7B761A04Q38960271-BC8FAB6E-8AE4-4846-9029-279CC7967F26Q39200736-21498AC2-97F6-4F48-97F7-DB2F1B35B32BQ39661408-4BD5602B-C164-459E-8252-3498C8C82497Q39813163-F451CE14-7817-476D-B02F-6006CC3A5368Q39854930-DC29FE9D-919C-46A3-85A0-41CFF4DC4387Q40242598-8B96B954-CA44-4E33-A4F9-64181A46D2DDQ40298613-06E2CD25-5C97-4D01-886F-AD80651693DCQ40693011-B2CA1702-04E0-41C8-8D36-617D778644B2Q40780392-7F07581C-8DC3-44DC-9968-CE4653335764Q42738528-8919FE41-900B-4E4B-A19A-C8CFF750B792Q47115918-F171F2DA-7E1B-4C06-9DE1-EBB1DC07D73CQ47739533-0465BF8E-DB9D-41FC-B2BE-64042C1DB8E3Q50143779-BDF44380-F426-4D3B-A5E6-3D2A97A6C6EBQ50679293-65802164-6DA8-4964-A3C9-3521B8A9BB38Q54575535-BE16AA30-7B8C-4AD4-94BF-9F8B7702D77DQ58550643-9E363D8D-1DEC-40A0-BE10-9983A62295F7
P2860
Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@en
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@nl
type
label
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@en
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@nl
prefLabel
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@en
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@nl
P2093
P2860
P356
P1476
Early impact of 13-valent pneu ...... cquired pneumonia in children.
@en
P2093
C Gras-Le Guen
E Grimprel
F Angoulvant
M A Dommergues
P2860
P304
P356
10.1093/CID/CIU006
P407
P577
2014-02-13T00:00:00Z